
LeMaitre Vascular Inc
NASDAQ:LMAT

Intrinsic Value
The intrinsic value of one
LMAT
stock under the Base Case scenario is
58.39
USD.
Compared to the current market price of 82.2 USD,
LeMaitre Vascular Inc
is
Overvalued by 29%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
LeMaitre Vascular Inc
Fundamental Analysis


Revenue & Expenses Breakdown
LeMaitre Vascular Inc
Balance Sheet Decomposition
LeMaitre Vascular Inc
Current Assets | 408.1m |
Cash & Short-Term Investments | 302.5m |
Receivables | 35.1m |
Other Current Assets | 70.5m |
Non-Current Assets | 147.9m |
PP&E | 41.3m |
Intangibles | 100.3m |
Other Non-Current Assets | 6.2m |
Free Cash Flow Analysis
LeMaitre Vascular Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
LeMaitre Vascular Inc
Revenue
|
226.3m
USD
|
Cost of Revenue
|
-70.6m
USD
|
Gross Profit
|
155.7m
USD
|
Operating Expenses
|
-102.6m
USD
|
Operating Income
|
53m
USD
|
Other Expenses
|
-7.8m
USD
|
Net Income
|
45.2m
USD
|
LMAT Profitability Score
Profitability Due Diligence
LeMaitre Vascular Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Score
LeMaitre Vascular Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
LMAT Solvency Score
Solvency Due Diligence
LeMaitre Vascular Inc's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Score
LeMaitre Vascular Inc's solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LMAT Price Targets Summary
LeMaitre Vascular Inc
According to Wall Street analysts, the average 1-year price target for
LMAT
is 106.59 USD
with a low forecast of 90.9 USD and a high forecast of 126 USD.
Dividends
Current shareholder yield for LMAT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
LMAT
stock under the Base Case scenario is
58.39
USD.
Compared to the current market price of 82.2 USD,
LeMaitre Vascular Inc
is
Overvalued by 29%.